GlycoMimetics (GLYC) Reports In-Line Q3 EPS

GlycoMimetics (NASDAQ: GLYC) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.

You May Also Be Interested In

• SpaceX: New Street Research sees 22% upside from proposed IPO price
• Nomura/Instinet Upgrades Mitsubishi Gas Chemical Co Inc (4182:JP) to Buy
• UBS Starts Motilal Oswal Financial Services Ltd (MOFS:IN) at Buy